![](/img/cover-not-exists.png)
Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a "Physician's Choice" Control Arm in a Randomized Approval Trial
Donoghue, M., Lemery, S. J., Yuan, W., He, K., Sridhara, R., Shord, S., Zhao, H., Marathe, A., Kotch, L., Jee, J., Wang, Y., Zhou, L., Adams, W. M., Jarral, V., Pilaro, A., Lostritto, R., Gootenberg,Volume:
18
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-11-2149
Date:
March, 2012
File:
PDF, 306 KB
english, 2012